- Rituximab, sold
under the
brand name
Rituxan among others, is a
monoclonal antibody medication used to
treat certain autoimmune diseases and
types of...
-
children and
young adults with
cystic fibrosis—recombinant DNAse. 1997:
Rituxan (rituximab):
Treatment for
specific kinds of non-Hodgkin's lymphomas. In...
-
dispute over
Rituxan follow-ons". Reuters. 21
October 2010.
Archived from the
original on 2014-07-27.
Retrieved 2010-10-21. "FDA
approves Rituxan to treat...
-
original on 2012-02-13.
Retrieved 2009-04-02. "FDA
Approves Genentech's
Rituxan (Rituximab) for
Pemphigus Vulgaris". Genentech.
Retrieved 24
December 2019...
- transplantation. In
combination with anti-CD20
monoclonal antibody rituximab (
Rituxan, Mabthera) it is
called R-DHAP or DHAP-R. [R]-DHAP
regimen consists of:...
- pegfilgrastim/Neulasta
November 2018 rituximab-abbs/Truxima rituximab/
Rituxan December 2018 trastuzumab-pkrb/Herzuma trastuzumab/Herceptin
January 2019...
- are infected.[citation needed] The
boxed warning for the drug
rituximab (
Rituxan)
includes a
statement that
Human polyomavirus 2
infection resulting in...
-
developed its
immunology and
ophthalmology divisions,
managed the
sales of
Rituxan, Raptiva, and Xolair, and
directed Roche's late-stage
portfolio committee...
- or
combinations of these. The off-label use of
rituximab (trade name
Rituxan) has
produced some good
results in
acute and
refractory cases, although...
-
combination drug
products in the
United States: rituximab/hyaluronidase (
Rituxan Hycela), trastuzumab/hyaluronidase-oysk (Herceptin Hylecta),...
